Table 2.

Baseline demographics for patients who were reviewed by the pharmacist

Patient characteristic	Patients involved in the pharmacy intervention (n=47)
Gender (male %)	66
Age (years, median, IQR)	52 (44–57)
ICU LOS (days, median, IQR)	15 (9–26)
APACHE II (median, IQR)	23 (19–27)
Charlson Comorbidity Index (median, IQR)	1 (0–2)
SIMD decile (median, IQR)	3 (1–4)
Interventions received in ICU
Mechanical ventilation (%)	94
RRT (%)	34
CVS (%)	47

APACHE II, Acute Physiology and Chronic Health Evaluation II; CVS, cardiovascular support (use of vasopressor therapy in the ICU); ICU LOS, intensive care unit length of stay; RRT, renal replacement therapy ; SIMD, Scottish Index of Multiple Deprivation.